Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapeutic compositions comprising a specific endothelin receptor antagonist and a PDE5 inhibitor

Therapeutic compositions comprising a specific endothelin receptor antagonist and a PDE5 inhibitor

US Patent 8268847 · Granted Sep 18, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical combination comprising a selective S1P1 receptor agonist2025
Combinations of a 4-pyrimidinesulfamide derivative with active ingredients for t2023
Pharmaceutical combination comprising ponesimod2023
Pharmaceutical combination comprising a selective S1P1 receptor agonist2023
Combinations of a 4-pyrimidinesulfamide derivative with active ingredients for t2021
Pharmaceutical combination comprising a selective S1P1 receptor agonist2021
Pharmaceutical combination comprising a selective S1P1 receptor agonist2019
Therapeutic compositions containing macitentan2017
Therapeutic compositions containing macitentan2015
Therapeutic compositions containing macitentan2014
Combination comprising macitentan and paclitaxel for treating multi-drug resista2013
Sulfamides as endothelin receptor antagonists for the treatment of cardiovascula2011